Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/5/2026

1. SPCX
2. AMD
3. DOX
4. BKNG
5. ANET
6. PINS
7. HNGE
8. TOST
9. SNDK
10. APTV

Go back to Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025
(NASDAQ: RLMD) Delayed: 5.44 -0.03 (0.55%)
Previous Close $5.47    52 Week High $4.10 
Open $5.51    52 Week Low $0.87 
Day High $5.54    P/E N/A 
Day Low $5.33    EPS $0.00 
Volume 827,308